Experts discuss how to navigate coding, reimbursement, and other potential financial strains when treating patients via radiotherapy.
Ron DiGiaimo, MBA, FACHE
Advertisement
Articles by Ron DiGiaimo, MBA, FACHE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Regulatory T-Cell Immunotherapy in Hematologic Malignancies
2
Zanubrutinib/Rituximab Improves PFS in Frontline Mantle Cell Lymphoma
3
Namodenoson Yields Durable Survival Outcomes in Pretreated Pancreatic Cancer
4
How Will EPCORE FL-1 Subgroup Data Impact R/R Follicular Lymphoma Care?
5